DMP Pharmaceuticals Corp.

$DMK is down over 20% as of now after finishing up big yesterday on news that the company received a patent in Canada for an opioid intended to treat drug addiction. The stock has been steadily declining since the end of February this year when the price was around $20. It now sits at around $0.60

Share This Article

 

About the Author

DMP Pharmaceuticals Corp.

Joey Ramson